Radov A. Jeffrey 4

4 · BioRestorative Therapies, Inc. · Filed Mar 25, 2019

Insider Transaction Report

Form 4

Period: 2019-03-25

BioRestorative Therapies, Inc.BRTX

Radov A. Jeffrey

Director

Transactions

Award
Stock Option
2019-03-25+5,000→ 5,000 total
Exercise: $0.75Exp: 2022-12-07→ Common Stock (5,000 underlying)
Award
Stock Option
2019-03-25+12,500→ 12,500 total
Exercise: $0.75Exp: 2023-10-04→ Common Stock (12,500 underlying)
Disposition to Issuer
Stock Option
2019-03-25−50,000→ 0 total
Exercise: $4.70Exp: 2024-10-23→ Common Stock (50,000 underlying)
Award
Stock Option
2019-03-25+115,500→ 115,500 total
Exercise: $0.75Exp: 2025-09-04→ Common Stock (115,500 underlying)
Award
Stock Option
2019-03-25+128,000→ 128,000 total
Exercise: $0.75Exp: 2026-06-10→ Common Stock (128,000 underlying)
Award
Stock Option
2019-03-25+125,000→ 125,000 total
Exercise: $0.75Exp: 2027-06-23→ Common Stock (125,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−30,000→ 0 total
Exercise: $4.70Exp: 2022-02-09→ Common Stock (30,000 underlying)
Award
Stock Option
2019-03-25+30,000→ 30,000 total
Exercise: $0.75Exp: 2022-02-09→ Common Stock (30,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−25,000→ 0 total
Exercise: $4.70Exp: 2024-02-18→ Common Stock (25,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−115,500→ 0 total
Exercise: $4.70Exp: 2025-09-04→ Common Stock (115,500 underlying)
Disposition to Issuer
Stock Option
2019-03-25−5,000→ 0 total
Exercise: $4.70Exp: 2022-12-07→ Common Stock (5,000 underlying)
Award
Stock Option
2019-03-25+25,000→ 25,000 total
Exercise: $0.75Exp: 2024-02-18→ Common Stock (25,000 underlying)
Award
Stock Option
2019-03-25+50,000→ 50,000 total
Exercise: $0.75Exp: 2024-10-23→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−125,000→ 0 total
Exercise: $3.35Exp: 2027-06-23→ Common Stock (125,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−75,000→ 0 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (75,000 underlying)
Award
Stock Option
2019-03-25+75,000→ 75,000 total
Exercise: $0.75Exp: 2028-10-29→ Common Stock (75,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−12,500→ 0 total
Exercise: $4.70Exp: 2023-10-04→ Common Stock (12,500 underlying)
Disposition to Issuer
Stock Option
2019-03-25−128,000→ 0 total
Exercise: $3.73Exp: 2026-06-10→ Common Stock (128,000 underlying)

Holdings

Common Stock
12,500

Footnotes (10)

[F1]The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013.
[F10]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.
[F2]The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013.
[F3]The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
[F4]The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016.
[F5]The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017.
[F6]The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
[F7]The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018.
[F8]The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
[F9]The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.

Documents

1 file

4
doc1.xmlPrimary
FORM 4